Guancydine: a new antihypertensive agent. Use with quinethazone and guanethidine or propranolol.
D000959:Antihypertensive Agents / Q000008:administration & dosage*; D001007:Anxiety; D001219:Aspartate Aminotransferases / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004487:Edema / Q000139:chemically induced; D004562:Electrocardiography; D005145:Face; D005260:Female; D006145:Guanethidine / Q000008:administration & dosage* / Q000627:therapeutic use; D006146:Guanidines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced; D010919:Placebos; D011433:Propranolol / Q000008:administration & dosage* / Q000627:therapeutic use; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D006146:Guanidines; D010919:Placebos; D013449:Sulfonamides; D011433:Propranolol; D001219:Aspartate Aminotransferases; D006145:Guanethidine